News
Fall 2009

The FTC Reports on Follow-on Biologics and Authorized Generics: Applying Lessons from Hatch-Waxman to Promote Competition

Antitrust

People

Asim Varma
Asim Varma
Partner
Washington, DC
Subscribe
Subscribe Link

Email Disclaimer